Literature DB >> 18306485

Rescue use of tirofiban for acute carotid in-stent thrombosis.

Kwon Duk Seo1, Kee Oog Lee, Dong Joon Kim, Kyung-Yul Lee.   

Abstract

Carotid artery stenting is widely performed for extracranial carotid artery stenosis. In-stent thrombosis is a rare but potentially devastating complication. We present a case of acute in-stent thrombosis immediately following stent insertion and post-balloon dilatation in a 64-year-old male. Thrombosis was successfully treated by intravenous tirofiban, a glycoprotein IIb/IIIa receptor inhibitor.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18306485      PMCID: PMC2615275          DOI: 10.3349/ymj.2008.49.1.163

Source DB:  PubMed          Journal:  Yonsei Med J        ISSN: 0513-5796            Impact factor:   2.759


  17 in total

1.  Carotid artery stenting: acute and long-term results.

Authors:  Fayaz A Shawl
Journal:  Curr Opin Cardiol       Date:  2002-11       Impact factor: 2.161

Review 2.  The role of antiplatelet therapy in carotid stenting for ischemic stroke prevention.

Authors:  Seemant Chaturvedi; Jay S Yadav
Journal:  Stroke       Date:  2006-04-20       Impact factor: 7.914

3.  Carotid angioplasty and stent placement: a prospective analysis of perioperative complications and impact of intravenously administered abciximab.

Authors:  Adnan I Qureshi; M Fareed K Suri; Zulfiqar Ali; Stanley H Kim; Giuseppe Lanzino; Richard D Fessler; Andrew J Ringer; Lee R Guterman; L Nelson Hopkins
Journal:  Neurosurgery       Date:  2002-03       Impact factor: 4.654

4.  Reoperation for acute hemispheric stroke after carotid endarterectomy: is there any value?

Authors:  J Max Findlay; B Elaine Marchak
Journal:  Neurosurgery       Date:  2002-03       Impact factor: 4.654

5.  Endovascular versus surgical treatment in patients with carotid stenosis in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS): a randomised trial.

Authors: 
Journal:  Lancet       Date:  2001-06-02       Impact factor: 79.321

6.  Carotid stent thrombosis: report of 2 fatal cases.

Authors:  S Chaturvedi; S Sohrab; A Tselis
Journal:  Stroke       Date:  2001-11       Impact factor: 7.914

7.  Initial experience of platelet glycoprotein IIb/IIIa inhibition with abciximab during carotid stenting: a safe and effective adjunctive therapy.

Authors:  S R Kapadia; C T Bajzer; K M Ziada; D L Bhatt; O M Wazni; M J Silver; E G Beven; K Ouriel; J S Yadav
Journal:  Stroke       Date:  2001-10       Impact factor: 7.914

8.  Abciximab rescue in acute carotid stent thrombosis.

Authors:  F C Tong; H J Cloft; G J Joseph; O B Samuels; J E Dion
Journal:  AJNR Am J Neuroradiol       Date:  2000-10       Impact factor: 3.825

9.  Evaluation of glycoprotein IIb/IIIa inhibitors in carotid angioplasty and stenting.

Authors:  Michael Henry Wholey; Mark Henry Wholey; Gustave Eles; Boulis Toursakissian; Steven Bailey; Chester Jarmolowski; Walter A Tan
Journal:  J Endovasc Ther       Date:  2003-02       Impact factor: 3.487

10.  Effects of GP IIb/IIIa receptor inhibitor tirofiban (aggrastat) in ex vivo canine arteriovenous shunt model of stent thrombosis.

Authors:  Vladimir Rukshin; Babak Azarbal; Ariel Finkelstein; Prediman K Shah; Bojan Cercek; Vivian Tsang; Sanjay Kaul
Journal:  J Cardiovasc Pharmacol       Date:  2003-04       Impact factor: 3.105

View more
  3 in total

1.  Safety and Efficacy of Tirofiban in Rescue Treatment for Acute Intracranial Intraprocedural Stent Thrombosis.

Authors:  Lili Sun; Jinping Zhang; Yun Song; Wei Zhao; Meimei Zheng; Jun Zhang; Hao Yin; Wei Wang; Yao Meng; Jiyou Tang; Ju Han
Journal:  Front Neurol       Date:  2020-06-16       Impact factor: 4.003

2.  Revascularization of acute stent thrombosis after carotid artery stenting in a CYP2C19*2 heterozygote patient.

Authors:  Wei Wei; Yan Wang; Pian Wang; Zheng Li
Journal:  J Int Med Res       Date:  2021-03       Impact factor: 1.671

3.  Acute carotid stent thrombosis: A case report and literature review.

Authors:  Jian-Bin Zhang; Xue-Qiang Fan; Jie Chen; Peng Liu; Zhi-Dong Ye
Journal:  World J Clin Cases       Date:  2022-09-16       Impact factor: 1.534

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.